What your patient might ask you…

I can’t remember to take my glaucoma drops – is there anything that lasts longer?

An extended-release travoprost implant announced positive phase 2 results for treating glaucoma.
The biodegradable implant, placed in the anterior chamber of glaucoma patients, showed a “clinically meaningful reduction in intraocular pressure for the entire 11 month evaluation period following a single administration”.
The investigators say, “glaucoma may become an easier-to-manage disease.  We would no longer have to be concerned with compliance and glaucoma specialists will no longer need to be concerned about the diurnal response of topical therapy.
Just imagine how this is would improve glaucoma care in both developed and in third-world countries.”